DK1069893T3 - Anvendelse af dexmedetomidin til sedering på en intensivafdeling - Google Patents

Anvendelse af dexmedetomidin til sedering på en intensivafdeling

Info

Publication number: DK1069893T3
Authority: DK; Denmark
Prior art keywords: dexmedetomidine; sedation; intensive care; care unit; intensive
Prior art date: 1998-04-01

Application number

DK99913332T

Other languages

Danish (da)

English (en)

Inventor

Riku Aantaa

Romeo Bachand

Esa Heinonen

Original Assignee

Orion Corp

Hospira Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-04-01

Filing date

1999-03-31

Publication date

2007-03-19

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26763325&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1069893(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1999-03-31 Application filed by Orion Corp, Hospira Inc filed Critical Orion Corp

2007-03-19 Application granted granted Critical

2007-03-19 Publication of DK1069893T3 publication Critical patent/DK1069893T3/da

Links

206010039897 Sedation Diseases 0.000 title 1
HRLIOXLXPOHXTA-NSHDSACASA-N dexmedetomidine Chemical compound C1([C@@H](C)C=2C(=C(C)C=CC=2)C)=CN=C[N]1 HRLIOXLXPOHXTA-NSHDSACASA-N 0.000 title 1
229960004253 dexmedetomidine Drugs 0.000 title 1
230000036280 sedation Effects 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4174—Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Anesthesiology (AREA)
Epidemiology (AREA)
Pain & Pain Management (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

DK99913332T 1998-04-01 1999-03-31 Anvendelse af dexmedetomidin til sedering på en intensivafdeling DK1069893T3 (da)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US8028798P	1998-04-01	1998-04-01
US11094498P	1998-12-04	1998-12-04
PCT/FI1999/000266 WO1999049854A2 (en)	1998-04-01	1999-03-31	Use of dexmedetomidine for icu sedation

Publications (1)

Publication Number	Publication Date
DK1069893T3 true DK1069893T3 (da)	2007-03-19

Family

ID=26763325

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK99913332T DK1069893T3 (da)	1998-04-01	1999-03-31	Anvendelse af dexmedetomidin til sedering på en intensivafdeling

Country Status (27)

Country	Link
EP (1)	EP1069893B1 (pl)
JP (1)	JP4606581B2 (pl)
KR (1)	KR20010034728A (pl)
CN (1)	CN1168441C (pl)
AR (1)	AR015744A1 (pl)
AT (1)	ATE347359T1 (pl)
AU (1)	AU754484B2 (pl)
BG (1)	BG64540B1 (pl)
BR (1)	BR9909872A (pl)
CA (1)	CA2326339C (pl)
CZ (1)	CZ301013B6 (pl)
DE (1)	DE69934305T2 (pl)
DK (1)	DK1069893T3 (pl)
EA (1)	EA005524B1 (pl)
ES (1)	ES2278441T3 (pl)
GB (1)	GB2352972B (pl)
HU (1)	HU229162B1 (pl)
IL (1)	IL138416A (pl)
NO (1)	NO329194B1 (pl)
NZ (1)	NZ507203A (pl)
PL (1)	PL192517B1 (pl)
PT (1)	PT1069893E (pl)
SI (1)	SI1069893T1 (pl)
SK (1)	SK286160B6 (pl)
TR (1)	TR200002837T2 (pl)
TW (1)	TW552136B (pl)
WO (1)	WO1999049854A2 (pl)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE60024855T2 (de)	1999-10-29	2006-08-31	Orion Corp.	Verwendung eines imidazolderivats zur behandlung oder verhütung von hypotension und schock
CA2480881C (en) *	2002-04-08	2012-09-11	Guilford Pharmaceuticals, Inc.	Pharmaceutical compositions containing water-soluble prodrugs of propofol and methods of administering same
US7141597B2 (en) *	2003-09-12	2006-11-28	Allergan, Inc.	Nonsedating α-2 agonists
US20060058700A1 (en) *	2004-08-26	2006-03-16	Marro Dominic P	Patient sedation monitor
ES2573253T3 (es)	2006-09-20	2016-06-06	The Board Of Regents Of The University Of Texas System	Métodos para el suministro de anestésicos volátiles para anestesia regional y/o alivio del dolor
EP3581169A1 (en)	2008-01-22	2019-12-18	The Board Of Regents Of The University Of Texas System	Volatile anesthetic compositions comprising extractive solvents for regional anesthesia and/or pain relief
RU2572692C2 (ru) *	2009-05-15	2016-01-20	Рекро Фарма, Инк.	Сублингвальные композиции дексмедетомидина и способы их применения
DE102009050016A1 (de)	2009-05-27	2011-05-05	Modine Manufacturing Co., Racine	Wärmeübertragereinheit
US20130096170A1 (en) *	2011-10-14	2013-04-18	Hospira, Inc.	Methods of treating pediatric patients using dexmedetomidine
AU2012352528B9 (en)	2011-12-11	2017-11-02	Baudax Bio, Inc.	Intranasal dexmedetomidine compositions and methods of use thereof
US8242158B1 (en) *	2012-01-04	2012-08-14	Hospira, Inc.	Dexmedetomidine premix formulation
JP5921928B2 (ja) *	2012-03-28	2016-05-24	テルモ株式会社	既希釈デクスメデトミジン製剤
DK2906213T3 (en) *	2012-10-15	2018-02-19	Orion Corp	VETERINARY PROCEDURE FOR RELIEFING NOISE SENSITIVITY
WO2015011177A1 (en)	2013-07-24	2015-01-29	I-Tech Ab	Use of the enantiomer levomedetomidine as inhibitor for marine biofouling of surfaces
BR112016006848A2 (pt)	2013-10-07	2017-08-01	Teikoku Pharma Usa Inc	métodos e composições para distribuição transdérmica de uma quantidade não sedativa de dexmedetomidina
KR101827980B1 (ko)	2013-10-07	2018-02-13	테이코쿠 팔마 유에스에이, 인코포레이티드	덱스메데토미딘 경피 전달 장치 및 이의 사용 방법
CA2924233C (en) *	2013-10-07	2018-10-23	Teikoku Pharma Usa, Inc.	Methods and compositions for treating attention deficit hyperactivity disorder, anxiety and insomnia using dexmedetomidine transdermal compositions
TWI764951B (zh)	2016-10-31	2022-05-21	美商帝國製藥美國股份有限公司	用於處理疼痛之右美托咪啶經皮遞送裝置
CN113975273B (zh) *	2020-07-27	2023-07-11	宜昌人福药业有限责任公司	一种抗焦虑用纳米混悬鼻腔喷雾剂及其制备方法
CN115197149B (zh) *	2021-04-02	2023-09-22	四川大学华西医院	一种5-苄基咪唑类化合物及其制备方法和用途

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB2101114B (en) *	1981-07-10	1985-05-22	Farmos Group Ltd	Substituted imidazole derivatives and their preparation and use
FI844786A0 (fi) *	1984-12-04	1984-12-04	Farmos Oy	Terapeutiskt utnyttjbar foerening.
GB2206880B (en) *	1987-07-16	1991-04-24	Farmos Oy	Optical isomers of an imidazole derivative
US5344840A (en) *	1988-02-29	1994-09-06	Orion-Yhtyma Oy	4-substituted imidazole derivatives useful in perioperative care
GB2215206B (en) *	1988-02-29	1991-07-03	Farmos Oy	4-substituted imidazole derivatives useful in perioperative care
US5124157A (en) *	1989-08-18	1992-06-23	Cygnus Therapeutic Systems	Method and device for administering dexmedetomidine transdermally
US5217718A (en) *	1989-08-18	1993-06-08	Cygnus Therapeutic Systems	Method and device for administering dexmedetomidine transdermally
FI894911A0 (fi) *	1989-10-17	1989-10-17	Farmos Oy	En terapeutiskt vaerdefull foerening.
GB2281206A (en) *	1993-08-25	1995-03-01	Orion Yhtymae Oy	Use of dexmedetomidine

1999
- 1999-03-30 AR ARP990101414A patent/AR015744A1/es unknown
- 1999-03-31 GB GB0024932A patent/GB2352972B/en not_active Expired - Lifetime
- 1999-03-31 BR BRPI9909872-5A patent/BR9909872A/pt not_active Application Discontinuation
- 1999-03-31 SK SK1436-2000A patent/SK286160B6/sk not_active IP Right Cessation
- 1999-03-31 ES ES99913332T patent/ES2278441T3/es not_active Expired - Lifetime
- 1999-03-31 CA CA002326339A patent/CA2326339C/en not_active Expired - Lifetime
- 1999-03-31 PT PT99913332T patent/PT1069893E/pt unknown
- 1999-03-31 TR TR2000/02837T patent/TR200002837T2/xx unknown
- 1999-03-31 DE DE69934305T patent/DE69934305T2/de not_active Expired - Lifetime
- 1999-03-31 HU HU0101498A patent/HU229162B1/hu unknown
- 1999-03-31 AU AU31494/99A patent/AU754484B2/en not_active Expired
- 1999-03-31 KR KR1020007010991A patent/KR20010034728A/ko not_active Ceased
- 1999-03-31 EP EP99913332A patent/EP1069893B1/en not_active Expired - Lifetime
- 1999-03-31 CZ CZ20003484A patent/CZ301013B6/cs not_active IP Right Cessation
- 1999-03-31 NZ NZ507203A patent/NZ507203A/xx not_active IP Right Cessation
- 1999-03-31 WO PCT/FI1999/000266 patent/WO1999049854A2/en not_active Ceased
- 1999-03-31 SI SI9930941T patent/SI1069893T1/sl unknown
- 1999-03-31 IL IL13841699A patent/IL138416A/xx not_active IP Right Cessation
- 1999-03-31 PL PL343553A patent/PL192517B1/pl unknown
- 1999-03-31 DK DK99913332T patent/DK1069893T3/da active
- 1999-03-31 JP JP2000540820A patent/JP4606581B2/ja not_active Expired - Lifetime
- 1999-03-31 EA EA200001010A patent/EA005524B1/ru not_active IP Right Cessation
- 1999-03-31 AT AT99913332T patent/ATE347359T1/de active
- 1999-03-31 CN CNB998046272A patent/CN1168441C/zh not_active Ceased
- 1999-04-01 TW TW088105188A patent/TW552136B/zh not_active IP Right Cessation
2000
- 2000-09-26 BG BG104797A patent/BG64540B1/bg unknown
- 2000-09-29 NO NO20004931A patent/NO329194B1/no not_active IP Right Cessation

Also Published As

Publication number	Publication date
BG104797A (en)	2001-07-31
GB2352972A (en)	2001-02-14
PT1069893E (pt)	2007-01-31
EA200001010A1 (ru)	2001-02-26
EA005524B1 (ru)	2005-04-28
CZ301013B6 (cs)	2009-10-14
EP1069893A2 (en)	2001-01-24
GB2352972B (en)	2003-05-21
JP4606581B2 (ja)	2011-01-05
ATE347359T1 (de)	2006-12-15
PL192517B1 (pl)	2006-10-31
ES2278441T3 (es)	2007-08-01
AU754484B2 (en)	2002-11-14
KR20010034728A (ko)	2001-04-25
NO20004931D0 (no)	2000-09-29
DE69934305D1 (de)	2007-01-18
TW552136B (en)	2003-09-11
WO1999049854A2 (en)	1999-10-07
EP1069893B1 (en)	2006-12-06
IL138416A (en)	2005-07-25
SK14362000A3 (sk)	2002-03-05
HUP0101498A3 (en)	2002-06-28
CA2326339A1 (en)	1999-10-07
HUP0101498A1 (hu)	2002-03-28
TR200002837T2 (tr)	2001-01-22
GB0024932D0 (en)	2000-11-29
CA2326339C (en)	2008-12-23
CN1295473A (zh)	2001-05-16
CN1168441C (zh)	2004-09-29
AU3149499A (en)	1999-10-18
DE69934305T2 (de)	2007-07-12
WO1999049854A3 (en)	1999-11-18
AR015744A1 (es)	2001-05-16
HU229162B1 (hu)	2013-09-30
JP2002509880A (ja)	2002-04-02
CZ20003484A3 (cs)	2002-01-16
SI1069893T1 (sl)	2007-04-30
NO20004931L (no)	2000-09-29
PL343553A1 (en)	2001-08-27
BG64540B1 (bg)	2005-07-29
BR9909872A (pt)	2007-11-20
IL138416A0 (en)	2001-10-31
NO329194B1 (no)	2010-09-13
SK286160B6 (sk)	2008-04-07
NZ507203A (en)	2003-03-28

Publication	Publication Date	Title
DK1069893T3 (da)	2007-03-19	Anvendelse af dexmedetomidin til sedering på en intensivafdeling
NO20005215D0 (no)	2000-10-17	Dihydropyrimidiner
FR2842417B1 (fr)	2005-01-21	Composition cosmetique
ID27768A (id)	2001-04-26	Komposisi-komposisi perawatan rambut
DE60016672D1 (de)	2005-01-20	Körpersreinigungsfolie
FR2824267B1 (fr)	2008-06-27	Composition cosmetique filmogene
DE69900634D1 (de)	2002-01-31	Shampoozusammensetzungen
DE59902843D1 (de)	2002-10-31	Brauseformulierungen
DE60321791D1 (de)	2008-08-07	Dynamisches routen in netzwerken
NO20043418L (no)	2004-08-17	Stabiliserte adenovirusformuleringer
ATE214590T1 (de)	2002-04-15	Körperpflegezusammensetzungen
DE69805443D1 (de)	2002-06-20	Sachet-formulierungen
ID30590A (id)	2002-01-03	Celana sekali pakai jenis-celana pendek
AR028087A1 (es)	2003-04-23	Composiciones cosmeticas
DE50110553D1 (de)	2006-09-07	Verwendung herbizider Mittel
DK1498124T3 (da)	2007-11-05	Anvendelse af inhibitorer i renin-angiotensinsystemet
ATE263487T1 (de)	2004-04-15	Flüssige formulierungen
DE69902473D1 (de)	2002-09-12	Kosmetikzusammensetzung
FR2781231B1 (fr)	2002-01-25	Compositions cosmetiques amincissantes
ID30226A (id)	2001-11-15	Komposisi penat rambut
DE60111988D1 (de)	2005-08-25	Kosmetische Zusammensetzung
ITMI20011532A0 (it)	2001-07-19	Cosmetico solido
DK1135381T3 (da)	2004-11-15	Eletriptanhydrobromidmonohydrat
FR2807317B1 (fr)	2002-08-16	Compositions de soin capillaire
DK1496918T3 (da)	2023-05-15	Anvendelse af natriummetaarsenit til behandling af tumorer